Gilead Sciences
About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Investment focus
Stages
Sectors
Portfolio (7 in our database)
Tizona TherapeuticsTizona develops next-generation immunotherapiesCorporate Round · $370M raisedPionyr ImmunotherapeuticsPionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.Corporate Round · $352M raisedTmunity TherapeuticsTmunity Therapeutics is developing novel products to unleash the immunological potential of T cellsSeries B · $230M raisedGoldfinch BiopharmaGoldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.Series B · $210M raisedLyndra TherapeuticsLyndra Therapeutics is a novel technology platform reinventing medicine for a healthier world.Series C · $163M raisedVinetiVineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies.Series C · $115M raisedKyverna TherapeuticsKyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.Series B · $110M raised